Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Rigaudeau

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Presse Medicale (Paris, France : 1983)|February 3, 2005
[Haemorrhagic fever viruses, possible bioterrorist use]Sophie Rigaudeau, François Bricaire, Philippe Bossi
Presse Medicale (Paris, France : 1983)|February 3, 2005
[Viral encephalitis virus, a new bioterrorist menace]Sophie Rigaudeau, Romain Micol, François Bricaire, et al.
The Pan African Medical Journal|July 22, 2022
[IgD multiple myeloma mimicking free light chain myeloma complicated by factor X deficiency: a case report]Najat Lasri, Fatimazahra Lahlimi, Mohammed Ilias Tazi, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 18, 2018
SkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extractsChristian Pellevoisin, Christelle Videau, Damien Briotet, et al.
International Journal of Molecular Sciences|May 10, 2019
Characterization of a New Reconstructed Full Thickness Skin Model, T-Skin™, and its Application for Investigations of Anti-Aging CompoundsMichel Bataillon, Damien Lelièvre, Adeline Chapuis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 27, 2009
Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MSOlivia Roth, Odile Spreux-Varoquaux, Stephane Bouchet, et al.
Infection Control and Hospital Epidemiology|June 25, 2016
The Plasmair Decontamination System Is Protective Against Invasive Aspergillosis in Neutropenic PatientsMarie-Paule Fernandez-Gerlinger, Anne-Sophie Jannot, Sophie Rigaudeau, et al.
Haematologica|October 8, 2008
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemiaJean-Valère Malfuson, Anne Etienne, Pascal Turlure, et al.
European Heart Journal. Cardiovascular Imaging|January 9, 2017
Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicityClément Charbonnel, Raphaele Convers-Domart, Sophie Rigaudeau, et al.
American Journal of Hematology|December 31, 2013
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapseSylvain Pilorge, Sophie Rigaudeau, Florence Rabian, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Presse Medicale (Paris, France : 1983)|February 3, 2005
[Haemorrhagic fever viruses, possible bioterrorist use]Sophie Rigaudeau, François Bricaire, Philippe Bossi
Presse Medicale (Paris, France : 1983)|February 3, 2005
[Viral encephalitis virus, a new bioterrorist menace]Sophie Rigaudeau, Romain Micol, François Bricaire, et al.
The Pan African Medical Journal|July 22, 2022
[IgD multiple myeloma mimicking free light chain myeloma complicated by factor X deficiency: a case report]Najat Lasri, Fatimazahra Lahlimi, Mohammed Ilias Tazi, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 18, 2018
SkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extractsChristian Pellevoisin, Christelle Videau, Damien Briotet, et al.
International Journal of Molecular Sciences|May 10, 2019
Characterization of a New Reconstructed Full Thickness Skin Model, T-Skin™, and its Application for Investigations of Anti-Aging CompoundsMichel Bataillon, Damien Lelièvre, Adeline Chapuis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 27, 2009
Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MSOlivia Roth, Odile Spreux-Varoquaux, Stephane Bouchet, et al.
Infection Control and Hospital Epidemiology|June 25, 2016
The Plasmair Decontamination System Is Protective Against Invasive Aspergillosis in Neutropenic PatientsMarie-Paule Fernandez-Gerlinger, Anne-Sophie Jannot, Sophie Rigaudeau, et al.
Haematologica|October 8, 2008
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemiaJean-Valère Malfuson, Anne Etienne, Pascal Turlure, et al.
European Heart Journal. Cardiovascular Imaging|January 9, 2017
Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicityClément Charbonnel, Raphaele Convers-Domart, Sophie Rigaudeau, et al.
American Journal of Hematology|December 31, 2013
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapseSylvain Pilorge, Sophie Rigaudeau, Florence Rabian, et al.
Pageof 3